The Role Observation About Shenzhi Mingdang Tang To Treat Chronic Pulmonary Heart Disease At Acute Stage

Background:Chronic pulmonary Heart Disease is a common disease and frequently encountered disease of respiratory apparatus.A survey about provinces、 municipalities、autonomous regions of5254822people over the age of14shows that the morbidity is a growing trend because of the social Aging factors in the recent10years. The disease take up5%～37%in all kinds of organic heart disease patients hospitalized. chronic pulmonary heart disease has rised from second to the first place on the organic cardiopathy in mang areas such as the northeast and southwest, has caused the attention of the Western and Chinese medicine experts. And at present,the side effects of only use wester routine treatment to cure Chronic Pulmonary heart Disease began to show up. such as the immune disorders and dysbacteriosis because of Long-term and many use antimicrobial therapy,Also, the situation of use sterilization drug therapy with endotoxin release and the emergence of bacteria resistant, It increased the difficulty of the fight infection、extended the time in hospital and raised a challenge about the treatment of chronic pulmonary Heart Disease acute pisode. Therefore, based on the western conventional treatment, our predecessors experts are actively searching for an optimal combine traditional Chinese and western medicine treatment to stop the progress of the disease rate for their best、changover the trend of the development of the disease and reduce the patients’ pain.with the basic theory of TCM and the guidance of teachers with YangZhouRui nearly thirty years of clinical experience.Objective:This topic using yiqi huoxue phlegm method (shenzhi mingdangtang) to treat chronic pulmonary Heart Disease about the type of insufficiency qi、Phlegm and stasis mutual. Methods:This topic select a small sample of prospectie、randomized、controlled parallel research plan. Select50inpatients (mainly for respiratory medicine) in Hospital of TCM in Guangzhou between April2010and March2012.50patients were randomly divided into2groups. The comprehensive therapy which combined Western routine treatment and shenzhi mingdang tang; while, control group were offered only western routine treatment. The experimental course was15days. Afterwards, the patients’ overall efficacy assessment、the main symptoms and signs、blood gas analysis、cardiac function、blood rheology index notably and patients’quality of life.Results:1、The treatment group’s total effective rate was92%, and control group’s total effective rate was64%, the curative effect of two chi-square test proved to be statistically significant (P<0.05).2、The outcomes of the main symptons and signs、blood gas analysis、 cardiac function、blood rheology index notably of treatment group were superior to control group,showing statistical significance(P<0.05). Conclusion:The comprehensive therapy of shenzhi mingdang tang to Treat and western medicine for pulmonary heart disease at acute stage proved to improve the overall efficacy symptons、signs、cardiac function、blood gas analysis results、blood rheology index notably and patients’ quality of life.